Ewing sarcoma is a rare and serious diagnosis, largely impacting children. The disease only accounts for about 1% of all pediatric cancers in the U.S., with about 250 children diagnosed every year, ...
Kids with a rare bone cancer might live longer if prescribed a drug that blocks blood supply to tumors, researchers say. The drug pazopanib (Votrient) extended the lives of a small group of kids with ...
Ewing sarcoma is one of the most common bone cancers seen in children, and if it spreads, it can be deadly. One study found that under a quarter of children with multi-metastatic Ewing sarcoma ...
Hosted on MSN
Young Woman Dies After Lower Back Pain Due to Bone Cancer Was Misdiagnosed As Sciatica; What Is Ewing Sarcoma?
A 25-year-old fit and athletic woman—whose lower back pain was misdiagnosed by the doctors—died of bone cancer less than a year after her tumour was finally discovered in the pelvis area. Kate ...
Immune Checkpoint Inhibitors in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Resistant Chemotherapy-Naïve Advanced Non–Small Cell Lung Cancer: A Meta-Analysis Based on Eight Randomized ...
CHICAGO and FORT WORTH, Texas, July 17, 2025 (GLOBE NEWSWIRE) -- Actuate Therapeutics, Inc. (NASDAQ: ACTU) (“Actuate” or the “Company”), a clinical-stage biopharmaceutical company focused on ...
Actuate Therapeutics, Inc. has announced the completion of the Phase 1 study evaluating its drug elraglusib in pediatric patients with refractory malignancies, specifically Ewing Sarcoma (EWS). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results